Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8712
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGruijs da Silva, Lara A.-
dc.contributor.authorSimonetti, Francesca-
dc.contributor.authorHutten, Saskia-
dc.contributor.authorRiemenschneider, Henrick-
dc.contributor.authorSternburg, Erin L.-
dc.contributor.authorPietrek, Lisa M.-
dc.contributor.authorGebel, Jakob-
dc.contributor.authorDötsch, Volker-
dc.contributor.authorEdbauer, Dieter-
dc.contributor.authorHummer, Gerhard-
dc.contributor.authorStelzl, Lukas S.-
dc.contributor.authorDormann, Dorothee-
dc.date.accessioned2023-02-03T12:05:32Z-
dc.date.available2023-02-03T12:05:32Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8728-
dc.description.abstractPost-translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis and frontotemporal dementia, the RNA-binding protein TAR DNA-binding protein (TDP-43), is hyperphosphorylated in disease on several Cterminal serine residues, a process generally believed to promote TDP-43 aggregation. Here, we however find that Casein kinase 1δ- mediated TDP-43 hyperphosphorylation or C-terminal phosphomimetic mutations reduce TDP-43 phase separation and aggregation, and instead render TDP-43 condensates more liquid-like and dynamic. Multi-scale molecular dynamics simulations reveal reduced homotypic interactions of TDP-43 low-complexity domains through enhanced solvation of phosphomimetic residues. Cellular experiments show that phosphomimetic substitutions do not affect nuclear import or RNA regulatory functions of TDP-43, but suppress accumulation of TDP-43 in membrane-less organelles and promote its solubility in neurons. We speculate that TDP-43 hyperphosphorylation may be a protective cellular response to counteract TDP-43 aggregation.en_GB
dc.description.sponsorshipGefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577de
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc570 Biowissenschaftende_DE
dc.subject.ddc570 Life sciencesen_GB
dc.titleDisease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregationen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-8712-
jgu.type.contenttypeScientific articlede
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 10 Biologiede
jgu.organisation.number7970-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleThe EMBO journalde
jgu.journal.volume41de
jgu.journal.issue8de
jgu.pages.alternative108443de
jgu.publisher.year2022-
jgu.publisher.nameWileyde
jgu.publisher.placeHoboken, NJde
jgu.publisher.issn1460-2075de
jgu.organisation.placeMainz-
jgu.subject.ddccode570de
jgu.publisher.doi10.15252/embj.2021108443de
jgu.organisation.rorhttps://ror.org/023b0x485-
jgu.subject.dfgNaturwissenschaftende
Appears in collections:DFG-491381577-H

Files in This Item:
  File Description SizeFormat
Thumbnail
diseaselinked_tdp43_hyperphos-20230130175249618.pdfHauptdatei6.73 MBAdobe PDFView/Open
Thumbnail
diseaselinked_tdp43_hyperphos-20230130175304603.pdfAppendix2.62 MBAdobe PDFView/Open
Thumbnail
diseaselinked_tdp43_hyperphos-20230130175316572.pdfExpanded view figures4.1 MBAdobe PDFView/Open